Pregnancy-related cell traffic, microchimerism and autoimmunity: the possibility of reducing autoimmune disease prevalence

References

• Bianchi DW, Romero R. Biological implications of bi-directional fetomaternal cell traffic: a summary of a National Institute of Child Health and Human Development-sponsored conference. J. Matern. Fetal Neonatal Med.14, 123–129 (2003).
   PubMedGoogle Scholar
• Adams KM, Nelson JL. Microchimerism. An investigative frontier in autoimmunity and transplantation. JAMA291, 1127–1131 (2004).
   PubMed Web of Science ®Google Scholar
• Maloney S, Smith A, Furst DE et al. Microchimerism of maternal origin persists into adult life. J. Clin. Invest.104, 41–47 (1999).
   PubMed Web of Science ®Google Scholar
• Aractingi S, Berkane N, Betheau P et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet352, 1898–1901 (1998).
   PubMed Web of Science ®Google Scholar
• Artlett CM, Smith B, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N. Engl. J. Med.338, 1186–1191 (1998).
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Miyamoto Y, Yamakage A, Yamazaki S. Quantitative analysis of microchimerism in systemic sclerosis skin tissue. Arch. Dermatol. Res.293, 387–391 (2001).
   PubMedGoogle Scholar
• Johnson K, Nelson JL, Furst DE et al. Fetal cell microchimerism in multiple tissues from multiple sites in women with systemic sclerosis. Arthritis Rheum.44, 1848–1854 (2001).
   PubMedGoogle Scholar
• Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: a case control study. Lancet358, 2034–2038 (2001).
   PubMed Web of Science ®Google Scholar
• Nelson JL. Microchimerism and autoimmune disease. N. Engl. J. Med.338, 1224–1225 (1998).
   PubMed Web of Science ®Google Scholar
• Turco AE, Bambara LM. Pregnancy, microchimerism and autoimmunity: an update. Lupus13, 659–660 (2004).
   PubMedGoogle Scholar
• Stevens AM, Hermes HM, Rutlege JC, Buyon JP, Nelson JL. Myocardial-tissue- specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet362, 1617–1623 (2003).
   PubMed Web of Science ®Google Scholar
• Christner PJ, Artlett CM, Conway RF, Jimenez SA. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum.43, 2598–2605 (2000).
   PubMedGoogle Scholar
• Walsh JP, Bremner AP, Bulsara MK et al. Parity and the risk of autoimmune thyroid disease: a community based study. J. Clin. Endocrinol. Metab.90, 5309–5312 (2005).
   PubMedGoogle Scholar
• Gannage M, Amoura Z, Lantz O, Piette JC, Caillat Zucman S. Feto-maternal microchimerism in connective tissue diseases. Eur. J. Immunol.32, 3405–3413 (2002).
   PubMedGoogle Scholar
• Kaneda T, Shiraki K, Hirano K, Nagata I. Detection of maternal fetal transfusion by placental alkaline phosphatase levels. J. Pediatr.111, 877–881 (1997).
   Google Scholar
• Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal–fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N. Engl. J. Med.329, 466–471 (1993).
   PubMed Web of Science ®Google Scholar
• Evans PC, Lamber N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and in women with scleroderma. Blood93, 2033–2037 (1999).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Demetri AJ, Trucco M et al. Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher disease. N. Engl. J. Med.328, 745–749 (1993).
   PubMed Web of Science ®Google Scholar
• Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet356, 2155–2156 (2000).
   PubMedGoogle Scholar
• Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW. Maternal cell microchimerism in newborn tissues. J. Pediatrics142, 31–35 (2003).
   PubMed Web of Science ®Google Scholar
• Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH. Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum. Reprod.15, 1624–1628 (2000).
   PubMed Web of Science ®Google Scholar
• Lo DYM, Leung TN, Tein MSC et al. Qualitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chemistry45, 184–188 (1999).
   PubMed Web of Science ®Google Scholar
• Zhong XY, Laivuori H, Livingston JC et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in plasma of pregnant women with preeclampsia. Am. J. Obstet. Gynecol.184, 414–419 (2001).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Why much of the pathophysiology of preeclampsia/eclampsia has to be “autoimmune” in nature. Am. J. Obstet. Gynecol.196, 5.e1–5.e7 (2007).
   PubMed Web of Science ®Google Scholar
• Rose CH, Thigpen BD, Bofill JA, Cushman J, May WL, Martin JN Jr. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet. Gynecol.104, 1011–1014 (2004).
   PubMed Web of Science ®Google Scholar
• Farina A, LeShane ES, Romero R et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol.193, 421–425 (2005).
   PubMed Web of Science ®Google Scholar
• El-Roeiy A, Myers SA, Gleicher N. The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol.164, 1253–1261 (1991).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yoshimura S, Geshi Y et al. Measurement of antiphospholipid antibody by ELISA using purified β-2-glycoprotein I in preeclampsia. Immunology94, 196–200 (1993).
   Web of Science ®Google Scholar
• Sheiner E, Ohel I, Levy A, Katz M. Pregnancy outcome in women with pruritus gravidarum. J. Reprod. Med.51, 394–398 (2006).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Pratt D, Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity16, 115–140 (1993).
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Farina A, Weber W et al. Significant fetal–maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am. J. Obstet. Gynecol.184, 703–706 (2001).
   PubMed Web of Science ®Google Scholar
• Davis AT. Clinical review 160: postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. J. Clin. Endocrinol. Metab.88, 2965–2971 (2003).
   PubMedGoogle Scholar
• Renne C, Ramos-Lopez E, Steimle-Grauer SA et al. Thyroid fetal male microchimerism in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto’s thyroiditis and Grave’s disease than in follicular adenomas. J. Clin. Endocrinol. Metab.89, 5810–5814 (2004).
   PubMedGoogle Scholar
• Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet368, 687 (2006).
   PubMed Web of Science ®Google Scholar
• Lin HH, Kao JH, Hsu HY. Least microtransfusion from mother to fetus in elective cesarean section delivery. Obstet. Gynecol.87, 244–248 (1996).
   PubMedGoogle Scholar
• Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA285, 709–717 (2001).
   PubMed Web of Science ®Google Scholar
• Gleicher N. Modern obstetrical and infertility care may increase the prevalence of disease. An evolutionary concept. Fertil. Steril.79, 249–252 (2003).
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet365, 785–799 (2005).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weiner R, Vietzky M. The impact of abnormal autoimmune function on reproduction: maternal and fetal consequences. J. Autoimmunity27, 161–165 (2006)
   PubMed Web of Science ®Google Scholar
• Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet. Gynecol.103, 1190–1193 (2004).
   PubMed Web of Science ®Google Scholar
• Skomsvoll JF, Baste V, Irgens LM, Ostensen M. The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic disease. Obstet. Gynecol.100, 1196–1202 (2002).
   PubMedGoogle Scholar